Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
DISCONTINUATION OF BCR-ABL1 TYROSINE KINASE INHIBITOR IN CML PATIENTS WITH UNDETECTABLE MOLECULAR RESIDUAL DISEASE FOR AT LEAST 1 YEAR: INCLUDING UPDATED DATA FROM KIDS STUDY
- Authors
- Oh, Y[Oh, Y.]; Lee, S[Lee, S.]; Choi, S[Choi, S.]; Bang, J[Bang, J.]; Kim, S[Kim, S.]; Jang, E[Jang, E.]; Park, J[Park, J.]; Jeon, H[Jeon, H.]; Kim, H[Kim, H.]; Kim, Y[Kim, Y.]; Park, J[Park, J.]; Jeong, S[Jeong, S.]; Kim, S[Kim, S.]; Zang, D[Zang, D.]; Oh, S[Oh, S.]; Koo, D[Koo, D.]; Kim, H[Kim, H.]; Do, Y[Do, Y.]; Kwak, J[Kwak, J.]; Kim, J[Kim, J.]; Kim, D[Kim, D.]; Mun, Y[Mun, Y.]; Kim, D[Kim, D.]
- Issue Date
- 12-Jun-2013
- Publisher
- FERRATA STORTI FOUNDATION
- Citation
- HAEMATOLOGICA, v.98, pp.62 - 62
- Indexed
- SCIE
SCOPUS
- Journal Title
- HAEMATOLOGICA
- Volume
- 98
- Start Page
- 62
- End Page
- 62
- ISSN
- 0390-6078
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.